Caplin Point Laboratories Ltd logo

Caplin Point Laboratories Ltd

NSE : CAPLIPOINT
BSE: 524742
SECTOR : PHARMACEUTICALS
No data to show from BSE
52w high/low icon
52w high/low
₹1034.8 / ₹401
P/E ratio icon
P/E ratio
29.94
Dividend icon
Dividend
0.27
ROE icon
ROE
20.19
ROCE icon
ROCE
26.81
Face value icon
Face value
2
Book value icon
Book value
₹122.78Cr
Market capital icon
Market capital
₹5,622.88Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.
Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:
Assets = Liabilities + Shareholder's Equity
This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM
29.94
P/B
6.04
ROE
20.19
ROCE
26.81
Dividend yield
0.27%
EPS TTM
24.78
EBTIDA Growth
-14.81
Sector PE
37.02
BV
₹122.78Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.
Caplin Point Laboratories Ltd logo

About Caplin Point Laboratories Ltd

Incorporated in the year 16th April, 1990 Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. As on 31 March 2019, the Company has four subsidiaries, viz Caplin Steriles Limited, Argus Salud Pharma LLP, Caplin Point Far East Limited - Hongkong and Caplin Point Laboratories Colombia SAS- Colombia. The company came out with a public issue in Nov. '94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies and Concord Laboratories, US, for specific products, with a 30% buyback arrangement.

Key info

Address
Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096
Telephone Nos.
91-44-24968000
Email
investor@caplinpoint.net/info@caplinepoint.net
fbtwitterlinkedingithubinstagramyoutube